Shift in Candidemia Epidemiology and Emerging Fluconazole Resistance in Candida parapsilosis: A Post-Pandemic Cohort Study in a Colombian High-Complexity Teaching Hospital †
Jenny Patricia Muñoz-Lombo, William David Cardales-Arizal, Raúl Andrés Vallejo-Serna, Indira Berrio · 2026
Read Shift in Candidemia Epidemiology and Emerging Fluconazole Resistance in Candida parapsilosis: A Post-Pandemic Cohort Study in a Colombian High-Complexity Teaching Hospital † by Jenny Patricia Muñoz-Lombo, William David Cardales-Arizal, Raúl Andrés Vallejo-Serna, Indira Berrio (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13413321.txt.
Description
Jenny Patricia Muñoz-Lombo and co-authors chart in 2026 how yeast blood infections changed after the pandemic at a large teaching hospital in Colombia. Their chart review covered adults with candidemia in 2022 and 2023. Labs named the yeast species and tested drug response in close to 3,500 blood cultures. Cases ran at just over one per thousand hospital stays, and near six per thousand in intensive care.
Yeasts other than Candida albicans caused 61.5 percent of the 109 cases found. Candida tropicalis and Candida parapsilosis led the list. Nearly three in ten parapsilosis samples shrugged off fluconazole, the main drug used against them. More than half the patients died. Those seen by an infection expert lived more often, so the authors press for expert input and stronger labs.
Catalog record
| CREATOR | Jenny Patricia Muñoz-Lombo, William David Cardales-Arizal, Raúl Andrés Vallejo-Serna, Indira Berrio |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 28313 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |